145 related articles for article (PubMed ID: 31765154)
1. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents.
Liu H; Ma J; Li Y; Yue K; Li L; Xi Z; Zhang X; Liu J; Feng K; Ma Q; Liu S; Guo S; Wang PG; Wang C; Xie S
J Med Chem; 2019 Dec; 62(24):11324-11334. PubMed ID: 31765154
[TBL] [Abstract][Full Text] [Related]
2. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.
Tummala R; Diegelman P; Fiuza SM; Batista de Carvalho LA; Marques MP; Kramer DL; Clark K; Vujcic S; Porter CW; Pendyala L
Oncol Rep; 2010 Jul; 24(1):15-24. PubMed ID: 20514439
[TBL] [Abstract][Full Text] [Related]
4. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
5. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
Chen F; Qin X; Xu G; Gou S; Jin X
Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047.
Murray-Stewart T; Ferrari E; Xie Y; Yu F; Marton LJ; Oupicky D; Casero RA
PLoS One; 2017; 12(4):e0175917. PubMed ID: 28423064
[TBL] [Abstract][Full Text] [Related]
7. Biochemical effects and growth inhibition in MCF-7 cells caused by novel sulphonamido oxa-polyamine derivatives.
Pavlov V; Lin PK; Rodilla V
Cell Mol Life Sci; 2002 Apr; 59(4):715-23. PubMed ID: 12022477
[TBL] [Abstract][Full Text] [Related]
8. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
[TBL] [Abstract][Full Text] [Related]
9. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
10. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
11. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
[TBL] [Abstract][Full Text] [Related]
12. The role of polyamine catabolism in polyamine analogue-induced programmed cell death.
Ha HC; Woster PM; Yager JD; Casero RA
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11557-62. PubMed ID: 9326648
[TBL] [Abstract][Full Text] [Related]
13. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
14. Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
Varma R; Hector S; Greco WR; Clark K; Hawthorn L; Porter C; Pendyala L
Cancer Chemother Pharmacol; 2007 May; 59(6):711-23. PubMed ID: 17021820
[TBL] [Abstract][Full Text] [Related]
15. Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer.
Zhu Y; Li J; Kanvinde S; Lin Z; Hazeldine S; Singh RK; Oupický D
Mol Pharm; 2015 Feb; 12(2):332-41. PubMed ID: 25153488
[TBL] [Abstract][Full Text] [Related]
16. Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines.
Obakan P; Arisan ED; Calcabrini A; Agostinelli E; Bolkent S; Palavan-Unsal N
Amino Acids; 2014 Mar; 46(3):553-64. PubMed ID: 23963538
[TBL] [Abstract][Full Text] [Related]
17. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
18. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
19. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
Wang L; Liu Z; He S; He S; Wang Y
J Mater Chem B; 2021 Jun; 9(22):4587-4595. PubMed ID: 34059856
[TBL] [Abstract][Full Text] [Related]
20. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
